RA Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,500,000
| Closed | -$15M | – | 71 |
|
|
2022
Q4 | $15M | Hold |
1,500,000
| – | – | 0.3% | 47 |
|
|
2022
Q3 | $14.6M | Hold |
1,500,000
| – | – | 0.31% | 55 |
|
|
2022
Q2 | $14.5M | Hold |
1,500,000
| – | – | 0.39% | 52 |
|
|
2022
Q1 | $14.6M | Hold |
1,500,000
| – | – | 0.32% | 65 |
|
|
2021
Q4 | $14.7M | Hold |
1,500,000
| – | – | 0.26% | 66 |
|
|
2021
Q3 | $14.7M | Buy |
+1,500,000
| New | +$14.7M | 0.2% | 68 |
|